Ascendis Pharma A/S announced that it has established oncology as its second independent therapeutic area. The company's oncology division is based in the San Francisco Bay Area.

To lead the oncology research and development programs, Ascendis recently appointed Juha Punnonen, MD, PhD, as Senior Vice President and Head of Oncology. Dr. Punnonen was most recently an Executive Director, Oncology Discovery Research, at Merck & Co. Inc.